Macrophages in hepatitis B and hepatitis C virus infections

Journal of Virology

Volumn 83, Issue 7, 2009, Pages 2796-2802

  Heydtmann, Mathis ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN RECOGNITION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISEASE COURSE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; LIVER; LIVER CANCER; LIVER CIRRHOSIS; LIVER FIBROSIS; MACROPHAGE; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION; IMMUNOLOGY;

HEPATITIS C VIRUS;

HEPATITIS B; HEPATITIS C; HUMANS; MACROPHAGES;

EID: 63149169012     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00996-08     Document Type: Review

References (99)

1. Abe, T., Y. Kaname, I. Hamamoto, Y. Tsuda, X. Wen, S. Taguwa, K. Moriishi, O. Takeuchi, T. Kawai, T. Kanto, N. Hayashi, S. Akira, and Y. Matsuura. 2007. Hepatitis C virus nonstructural protein 5A modulates the Toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines. J. Virol. 81:8953-8966.
2. Bellone, M., G. Iezzi, P. Rovere, G. Galati, A. Ronchetti, M. P. Protti, J. Davoust, C. Rugarli, and A. A. Manfredi. 1997. Processing of engulfed apoptotic bodies yields T cell epitopes. J. Immunol. 159:5391-5399.
3. Bilzer, M., F. Roggel, and A. L. Gerbes. 2006. Role of Kupffer cells in host defense and liver disease. Liver Int. 26:1175-1186.
4. Blight, K., R. Trowbridge, R. Rowland, and E. Gowans. 1992. Detection of hepatitis C virus RNA by in situ hybridization. Liver 12:286-289.
5. Bode, J. G., E. D. Brenndorfer, and D. Haussinger. 2007. Subversion of innate host antiviral strategies by the hepatitis C virus. Arch. Biochem. Biophys. 462:254-265.
6. Bonte, D., C. Francois, S. Castelain, C. Wychowski, J. Dubuisson, E. F. Meurs, and G. Duverlie. 2004. Positive effect of the hepatitis C virus nonstructural 5A protein on viral multiplication. Arch. Virol. 149:1353-1371.
7. Bowen, D. G., and C. M. Walker. 2005. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436:946-952.
8. Burgio, V. L., G. Ballardini, M. Artini, M. Caratozzolo, F. B. Bianchi, and M. Levrero. 1998. Expression of co-stimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology. Hepatology 27:1600-1606.
9. Caussin-Schwemling, C., C. Schmitt, and F. Stoll-Keller. 2001. Study of the infection of human blood derived monocyte/macrophages with hepatitis C virus in vitro. J. Med. Virol. 65:14-22.
10. Cooper, A., G. Tal, O. Lider, and Y. Shaul. 2005. Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2. J. Immunol. 175:3165-3176.
11. Cousens, L. P., and E. J. Wing. 2000. Innate defenses in the liver during Listeria infection. Immunol. Rev. 174:150-159.
12. Curbishley, S. M., B. Eksteen, R. P. Gladue, P. Lalor, and D. H. Adams. 2005. CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am. J. Pathol. 167:887-899.
13. de Fougerolles, A. R., G. Chi-Rosso, A. Bajardi, P. Gotwals, C. D. Green, and V. E. Koteliansky. 2000. Global expression analysis of extracellular matrixintegrin interactions in monocytes. Immunity 13:749-758.
14. Dolganiuc, A., S. Chang, K. Kodys, P. Mandrekar, G. Bakis, M. Cormier, and G. Szabo. 2006. Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-α and plasmacytoid dendritic cell loss in chronic HCV infection. J. Immunol. 177:6758-6768.
15. Dolganiuc, A., O. Norkina, K. Kodys, D. Catalano, G. Bakis, C. Marshall, P. Mandrekar, and G. Szabo. 2007. Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology 133:1627-1636.
16. Dolganiuc, A., S. Oak, K. Kodys, D. T. Golenbock, R. W. Finberg, E. Kurt-Jones, and G. Szabo. 2004. Hepatitis C core and nonstractural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127:1513-1524.
17. Doyle, A. G., G. Herbein, L. J. Montaner, A. J. Minty, D. Caput, P. Ferrara, and S. Gordon. 1994. Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma. Eur. J. Immunol. 24:1441-1445.
18. Outfield, J. S., S. J. Forbes, C. M. Constandinou, S. Clay, M. Partolina, S. Vuthoori, S. Wu, R. Lang, and J. P. Iredale. 2005. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Investig. 115:56-65.
19. Ehrt, S., D. Schnappinger, S. Bekiranov, J. Drenkow, S. Shi, T. R. Gingeras, T. Gaasterland, G. Schoolnik, and C. Nathan. 2001. Reprogramming of the macrophage transcriptome in response to interferon-γ and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 194:1123-1140.
20. Falcón, V., N. Acosta-Rivero, M. Shibayama, G. Chinea, J. V. Gavilondo, M. C. de la Rosa, I. Menendez, B. Gra, S. Duenas-Carrera, A. Vina, W. Garcia, M. Gonzalez-Bravo, J. Luna-Munoz, M. Miranda-Sanchez, J. Morales-Grillo, J. Kouri, and V. Tsutsumi. 2005. HCV core protein localizes in the nuclei of nonparenchymal liver cells from chronically HCV-infected patients. Biochem. Biophys. Res. Commun. 329:1320-1328.
21. Fallowfield, J. A., M. Mizuno, T. J. Kendall, C. M. Constandinou, R. C. Benyon, J. S. Duffield, and J. P. Iredale. 2007. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J. Immunol. 178:5288-5295.
22. Fenton, M. J., J. A. Buras, and R. P. Donnelly. 1992. IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. J. Immunol. 149:1283-1288.
23. Ferré, N., and J. Claria. 2006. New insights into the regulation of liver inflammation and oxidative stress. Mini-Rev. Med. Chem. 6:1321-1330.
24. Fillon, S., K. Klingel, S. Warntges, M. Sauter, S. Gabrysch, S. Pestel, V. Tanneur, S. Waldegger, A. Zipfel, R. Viebahn, D. Haussinger, S. Broer, R. Kandolf, and F. Lang. 2002. Expression of the serine/threonine kinase hSGK1 in chronic viral hepatitis. Cell. Physiol. Biochem. 12:47-54.
25. Girard, S., P. Shalhoub, P. Lescure, A. Sabile, D. E. Misek, S. Hanash, C. Brechot, and L. Beretta. 2002. An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. Virology 295:272-283.
26. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35.
27. Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5:953-964.
28. Guidotti, L. G., and F. V. Chisari. 2006. Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol. 1:23-61.
29. Hagen, T. M., S. Huang, J. Curnutte, P. Fowler, V. Martinez, C. M. Wehr, B. N. Ames, and F. V. Chisari. 1994. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 91:12808-12812.
30. Helbig, K. J., E. Yip, E. M. McCartney, N. S. Eyre, and M. R. Beard. 2008. A screening method for identifying disruptions in interferon signaling reveals HCV NS3/4a disrupts Stat-1 phosphorylation. Antivir. Res. 77:169-176.
31. Heydtmann, M., P. Shields, G. McCaughan, and D. Adams. 2001. Cytokines and chemokines in the immune response to hepatitis C infection. Curr. Opin. Infect. Dis. 14:279-287.
32. Hoshida, Y., N. Kato, H. Yoshida, Y. Wang, M. Tanaka, T. Goto, M. Otsuka, H. Taniguchi, M. Moriyama, F. Imazeki, O. Yokosuka, T. Kawabe, Y. Shiratori, and M. Omata. 2005. Hepatitis C virus core protein and hepatitis activity are associated through transactivation of interleukin-8. J. Infect. Dis. 192:266-275.
33. Isogawa, M., M. D. Robek, Y. Furuichi, and F. V. Chisari. 2005. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J. Virol. 79:7269-7272.
34. Jakubzick, C., E. S. Choi, S. L. Kunkel, B. H. Joshi, R. K. Puri, and C. M. Hogaboam. 2003. Impact of interleukin-13 responsiveness on the synthetic and proliferative properties of Th1- and Th2-type pulmonary granuloma fibroblasts. Am. J. Pathol. 162:1475-1486.
35. Kadoya, H., M. Nagano-Fujii, L. Deng, N. Nakazono, and H. Hotta. 2005. Nonstractural proteins 4A and 4B of hepatitis C virus transactivate the interleukin 8 promoter. Microbiol. Immunol. 49:265-273.
36. Kanto, T., and N. Hayashi. 2006. Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity. Intern. Med. 45:183-191.
37. Khabar, K. S., and S. J. Polyak. 2002. Hepatitis C virus-host interactions: the NS5A protein and the interferon/chemokine systems. J. Interferon Cytokine Res. 22:1005-1012.
38. Khakoo, S. I., P. N. Soni, K. Savage, D. Brown, A. P. Dhillon, L. W. Poulter, and G. M. Dusheiko. 1997. Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Correlation with disease activity. Am. J. Pathol. 150:963-970.
39. Khakoo, S. I., C. L. Thio, M. P. Martin, C. R. Brooks, X. Gao, J. Astemborski, J. Cheng, J. J. Goedert, D. Vlahov, M. Hilgartner, S. Cox, A. M. Little, G. J. Alexander, M. E. Cramp, S. J. O'Brien, W. M. Rosenberg, D. L. Thomas, and M. Carrington. 2004. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305:872-874.
40. Kluth, D. C., L. P. Erwig, and A. J. Rees. 2004. Multiple facets of macrophages in renal injury. Kidney Int. 66:542-557.
41. Knolle, P. A., and G. Gerken. 2000. Local control of the immune response in the liver. Immunol. Rev. 174:21-34.
42. Kolios, G., V. Valatas, and E. Kouroumalis. 2006. Role of Kupffer cells in the pathogenesis of liver disease. World J. Gastroenterol. 12:7413-7420.
43. Lalor, P. F., and D. H. Adams. 2002. The liver: a model of organ-specific lymphocyte recruitment. Expert Rev. Mol. Med. 4:1-16.
44. Laskus, T., M. Radkowski, D. M. Adair, J. Wilkinson, A. C. Scheck, and J. Rakela. 2005. Emerging evidence of hepatitis C virus neuroinvasion. Aids 19(Suppl. 3):S140-S144.
45. Lee, C. H., Y. H. Choi, S. H. Yang, C. W. Lee, S. J. Ha, and Y. C. Sung. 2001. Hepatitis C virus core protein inhibits interleukin 12 and nitric oxide production from activated macrophages. Virology 279:271-279.
46. Li, K., E. Foy, J. C. Ferreon, M. Nakamura, A. C. Ferreon, M. Ikeda, S. C. Ray, M. Gale, Jr., and S. M. Lemon. 2005. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. USA 102:2992-2997.
47. Ma, J., T. Chen, J. Mandelin, A. Ceponis, N. E. Miller, M. Hukkanen, G. F. Ma, and Y. T. Konttinen. 2003. Regulation of macrophage activation. Cell. Mol. Life Sci. 60:2334-2346.
48. Majano, P. L., and C. Garcia-Monzon. 2003. Does nitric oxide play a pathogenic role in hepatitis C virus infection? Cell Death Differ. 10(Suppl. 1): S13-S15.
49. Marrogi, A. J., M. K. Cheles, and M. A. Gerber. 1995. Chronic hepatitis C. Analysis of host immune response by immunohistochemistry. Arch. Pathol. Lab. Med. 119:232-237.
50. Mathur, R. K., A. Awasthi, and B. Saha. 2006. The conundrum of CD40 function: host protection or disease promotion? Trends Parasitol. 22:117-122.
51. Matlack, R., K. Yeh, L. Rosini, D. Gonzalez, J. Taylor, D. Silberman, A. Pennello, and J. Riggs. 2006. Peritoneal macrophages suppress T-cell activation by amino acid catabolism. Immunology 117:386-395.
52. Matsuno, K., H. Nomiyama, H. Yoneyama, and R. Uwatoku. 2002. Kupffer cell-mediated recruitment of dendritic cells to the liver crucial for a host defense. Dev. Immunol. 9:143-149.
53. McGuinness, P. H., D. Painter, S. Davies, and G. W. McCaughan. 2000. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut 46:260-269.
54. Mihm, U., E. Herrmann, U. Sarrazin, M. von Wagner, B. Kronenberger, S. Zeuzem, and C. Sarrazin. 2004. Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C. J. Hepatol. 40:845-852.
55. Mills, C. D., K. Kincaid, J. M. Alt, M. J. Heilman, and A. M. Hill. 2000. M-l/M-2 macrophages and the Thl/Th2 paradigm. J. Immunol. 164:6166-6173.
56. Monney, L., C. A. Sabatos, J. L. Gaglia, A. Ryu, H. Waldner, T. Chernova, S. Manning, E. A. Greenfield, A. J. Coyle, R. A. Sobel, G. J. Freeman, and V. K. Kuchroo. 2002. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415:536-541.
57. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19: 683-765.
58. Moorman, J. P., S. M. Fitzgerald, D. C. Prayther, S. A. Lee, D. S. Chi, and G. Krishnaswamy. 2005. Induction of p38- and gC1qR-dependent IL-8 expression in pulmonary fibroblasts by soluble hepatitis C core protein. Respir. Res. 6:105.
59. Mosser, D. M. 2003. The many faces of macrophage activation. J. Leukoc. Biol. 73:209-212.
60. Naugler, W. E., T. Sakurai, S. Kim, S. Maeda, K. Kim, A. M. Elsharkawy, and M. Karin. 2007. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317:121-124.
61. Oquendo, J., S. Karray, P. Galanaud, and M. A. Petit. 1997. Effect of hepatitis B virus on tumour necrosis factor (TNF alpha) gene expression in human THP-1 monocytic and Namalwa B-cell lines. Res. Immunol. 148:399-409.
62. Otsuka, M, N. Kato, M. Moriyama, H. Taniguchi, Y. Wang, N. Dharel, T. Kawabe, and M. Omata. 2005. Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses. Hepatology 41:1004-1012.
63. Parker, G. A., and C. A. Picut. 2005. Liver immunobiology. Toxicol. Pathol. 33:52-62.
64. Park-Min, K. H., T. T. Antoniv, and L. B. Ivashkiv. 2005. Regulation of macrophage phenotype by long-term exposure to IL-10. Immunobiology 210:77-86.
65. Polakos, N. K., J. C. Cornejo, D. A. Murray, K. O. Wright, J. J. Treanor, I. N. Crispe, D. J. Topham, and R. H. Pierce. 2006. Kupffer cell-dependent hepatitis occurs during influenza infection. Am. J. Pathol. 168:1169-1178.
66. Polyak, S. J., K. S. Khabar, D. M. Paschal, H. J. Ezelle, G. Duverlie, G. N. Barber, D. E. Levy, N. Mukaida, and D. R. Gretch. 2001. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J. Virol. 75:6095-6106.
67. Polyak, S. J., K. S. Khabar, M. Rezeiq, and D. R. Gretch. 2001. Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J. Virol. 75:6209-6211.
68. Racanelli, V., and B. Rehermann. 2006. The liver as an immunological organ. Hepatology 43:S54-62.
69. Radkowski, M., A. Bednarska, A. Horban, J. Stanczak, J. Wilkinson, D. M. Adair, M. Nowicki, J. Rakela, and T. Laskus. 2004. Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-alpha and interleukin 8. J. Gen. Virol. 85:47-59.
70. Rehermann, B., and M. Nascimbeni. 2005. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5:215-229.
71. Ren, Y., R. T. Poon, H. T. Tsui, W. H. Chen, Z. Li, C. Lau, W. C. Yu, and S. T. Fan. 2003. Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis. Clin. Cancer Res. 9:5996-6001.
72. Revie, D., R. S. Braich, D. Bayles, N. Chelyapov, R. Khan, C. Geer, R. Reisman, A. S. Kelley, J. G. Prichard, and S. Z. Salahuddin. 2005. Transmission of human hepatitis C virus from patients in secondary cells for long term culture. Virol. J. 2:37.
73. Ricote, M., A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass. 1998. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391:79-82.
74. Royer, C., A. M. Stefan, M. C. Navas, A. Fuchs, D. Jaeck, and F. StollKeller. 2003. A study of susceptibility of primary human Kupffer cells to hepatitis C virus. J. Hepatol. 38:250-256.
75. Salazar-Mather, T. P., and K. L. Hokeness. 2006. Cytokine and chemokine networks: pathways to antiviral defense. Curr. Top. Microbiol. Immunol. 303:29-46.
76. Schulz, O., S. S. Diebold, M. Chen, T. I. Naslund, M. A. Nolte, L. Alexopoulou, Y. T. Azuma, R. A. Flavell, P. Liljestrom, and C. Reis e Sousa. 2005. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433:887-892.
77. Schwabe, R. F., E. Seki, and D. A. Brenner. 2006. Toll-like receptor signaling in the liver. Gastroenterology 130:1886-1900.
78. Shapiro, S. D., E. J. Campbell, D. K. Kobayashi, and H. G. Welgus. 1990. Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. J. Clin. Investig. 86:1204-1210.
79. Shapiro, S. D., D. K. Kobayashi, A. P. Pentland, and H. G. Welgus. 1993. Induction of macrophage metalloproteinases by extracellular matrix. Evidence for enzyme- and substrate-specific responses involving prostaglandindependent mechanisms. J. Biol. Chem. 268:8170-8175.
80. Smith, M. W., Z. N. Yue, M. J. Korth, H. A. Do, L. Boix, N. Fausto, J. Bruix, R. L. Carithers, Jr., and M. G. Katze. 2003. Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers. Hepatology 38:1458-1467.
81. Sobaniec-Lotowska, M. E., J. M. Lotowska, and D. M. Lebensztejn. 2007. Ultrastructure of oval cells in children with chronic hepatitis B, with special emphasis on the stage of liver fibrosis: the first pediatric study. World J. Gastroenterol. 13:2918-2922.
82. Spengler, U., and J. Nattermann. 2007. Immunopathogenesis in hepatitis C virus cirrhosis. Clin. Sci. (London) 112:141-155.
83. Stein, M., S. Keshav, N. Harris, and S. Gordon. 1992. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176:287-292.
84. Stetson, D. B., and R. Medzhitov. 2006. Type I interferons in host defense. Immunity 25:373-381.
85. Su, A. I., J. P. Pezacki, L. Wodicka, A. D. Brideau, L. Supekova, R. Thimme, S. Wieland, J. Bukh, R. H. Purcell, P. G. Schultz, and F. V. Chisari. 2002. Genomic analysis of the host response to hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 99:15669-15674.
86. Sun, Z., T. Wada, K. Maemura, K. Uchikura, S. Hoshino, A. M. Diehl, and A. S. Klein. 2003. Hepatic allograft-derived Kupffer cells regulate T cell response in rats. Liver Transplant. 9:489-97.
87. Szabo, G., P. Mandrekar, and A. Dolganiuc. 2007. Innate immune response and hepatic inflammation. Semin. Liver Dis. 27:339-350.
88. Taams, L. S., L. W. Poulter, M. H. Rustin, and A N. Akbar. 1999. Phenotypic analysis of IL-10-treated macrophages using the monoclonal antibodies RFD1 and RFD7. Pathobiology 67:249-252.
89. Tang, T. J., J. Kwekkeboom, J. D. Laman, H. G. Niesters, P. E. Zondervan, R. A. de Man, S. W. Schalm, and H. L. Janssen. 2003. The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection. J. Viral Hepat. 10:159-167.
90. Taylor, P. R., L. Martinez-Pomares, M. Stacey, H. H. Lin, G. D. Brown, and S. Gordon. 2005. Macrophage receptors and immune recognition. Annu. Rev. Immunol. 23:901-944.
91. Tomita, M., K. Yamamoto, H. Kobashi, M. Ohmoto, and T. Tsuji. 1994. Immunohistochemical phenotyping of liver macrophages in normal and diseased human liver. Hepatology 20:317-325.
92. Villacres, M. C., O. Literat, M. DeGiacomo, W. Du, T. Frederick, and A. Kovacs. 2008. Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection. J. Viral Hepat. 15:137-144.
93. Visvanathan, K., N. A. Skinner, A. J. Thompson, S. M. Riordan, V. Sozzi, R. Edwards, S. Rodgers, J. Kurtovic, J. Chang, S. Lewin, P. Desmond, and S. Locarnini. 2007. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 45:102-110.
94. Waggoner, S. N., M. W. Cruise, R. Kassel, and Y. S. Hahn. 2005. gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway. J. Immunol. 175:4706-4714.
95. Wieland, S., R. Thimme, R. H. Purcell, and F. V. Chisari. 2004. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 101:6669-6674.
96. Woitas, R. P., U. Petersen, D. Moshage, H. H. Brackmann, B. Matz, T. Sauerbruch, and U. Spengler. 2002. HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C. World J. Gastroenterol. 8:562-566.
97. Wu, J., M. Lu, Z. Meng, M. Trippler, R. Broering, A. Szczeponek, F. Krux, U. Dittmer, M. Roggendorf, G. Gerken, and J. F. Schlaak. 2007. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 46:1769-1778.
98. Yamamoto, K., M. Ohmoto, S. Matsumoto, T. Nagano, H. Kobashi, R. Okamoto, and T. Tsuji. 1995. Activated liver macrophages in human liver diseases. J. Gastroenterol. Hepatol. 10(Suppl. 1):S72-S76.
99. Yoneyama, H., and T. Ichida. 2005. Recruitment of dendritic cells to pathological niches in inflamed liver. Med. Mol. Morphol. 38:136-141.